• Organization: U.S. Department of Health & Human Services
• Updated: 2025-09-06

Background Severe allergic reactions during rush-specific immunotherapy (Rush-SIT) may occur in the treatment of hymenoptera sting allergy. The objective of the present study was to...

• html

• Organization: U.S. Department of Health & Human Services
• Updated: 2025-09-06

We have recently found that matrix metalloproteinases (MMPs) are targets for T-cell and B-cell reactivity in experimental arthritis. In the present article, we investigate whether modulation of...

• html

• Organization: U.S. Department of Health & Human Services
• Updated: 2025-09-06

Background It is not uncommon to observe circulating tumor antigen-specific T lymphocytes in cancer patients despite a lack of significant infiltration and destruction of their tumors....

• html

• Organization: U.S. Department of Health & Human Services
• Updated: 2025-09-06

Background Hep27 monoclonal (Hep27 Mab) is an antibody against hepatocellular carcinoma. Hep27 Mab itself can inhibit the growth of a hepatocellular carcinoma cell line (HCC-S102). We...

• html

• Organization: U.S. Department of Health & Human Services
• Updated: 2025-09-06

Deficient microbial stimulation of the immune system, caused by hygiene, may underly the atopy and allergic asthma epidemic we are currently experiencing. Consistent with this 'hygiene...

• html

• Organization: U.S. Department of Health & Human Services
• Updated: 2025-03-17

BAVENCIO (avelumab) is a prescription monoclonal antibody used in immunotherapy to treat certain cancers by blocking PD-L1, helping the immune system fight tumor cells. It's given as an...

• html

• Organization: U.S. Department of Health & Human Services
• Updated: 2025-09-06

Compounds and methods for the treatment and diagnosis of lung cancer are provided. The inventive compounds include polypeptides containing at least a portion of a lung tumor protein. Vaccines and...

• html

• Organization: U.S. Department of Health & Human Services
• Updated: 2025-03-17

TEVIMBRA (tislelizumab-jsgr) is an intravenous injection used as an immunotherapy drug that blocks programmed death receptor-1 (PD-1) to help the immune system fight certain cancers. Manufactured...

• html

• Organization: U.S. Department of Health & Human Services
• Updated: 2025-09-06

The limitations of currently available treatment for severe respiratory infection are demonstrated by the relatively fixed mortality associated with these infections despite advances in nutrition,...

• html

• Organization: U.S. Department of Health & Human Services
• Updated: 2025-09-06

The Buzz and the Sting

• html

• Organization: U.S. Department of Health & Human Services
• Updated: 2025-09-06

Regulatory T cells prevent autoimmunity by suppressing the reactivity of potentially aggressive self-reactive T cells. Contact-dependent CD4+ CD25+ 'professional' suppressor cells and other...

• html